Quanterix Corporation
QUANTITATIVE ANTIBODY TEST
Last updated:
Abstract:
The present disclosure relates to methods and compositions, e.g., kits, for quantitatively detecting an antibody of a subject to an infectious organism. In some embodiments, the present disclosure provides for methods and compositions, e.g., kits, for quantitatively detecting a human antibody to SARS-CoV-2 polypeptide or S (spike) polypeptide. Certain applications and uses of the present methods and compositions, e.g., kits, are also provided.
Status:
Application
Type:
Utility
Filling date:
28 Apr 2021
Issue date:
4 Nov 2021